GLYDERM
Total Payments
$58,350
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $58,350 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $58,350 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The Effect of Cosmetic Face Peel Regimens on Skin Appearance | Mission Pharmacal Company | $40,850 | 1 |
| The Effect of a Novel Topical Gel on Nail Appearance | Mission Pharmacal Company | $17,500 | 1 |
Top Doctors Receiving Payments for GLYDERM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Dermatology | High Point, NC | $58,350 | 3 |
Ad
Manufacturing Companies
- Mission Pharmacal Company $58,350
Product Information
- Type Drug
- Total Payments $58,350
- Total Doctors 1
- Transactions 3
About GLYDERM
GLYDERM is a drug associated with $58,350 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Mission Pharmacal Company.
Payment data is available from 2017 to 2017. In 2017, $58,350 was paid across 3 transactions to 1 doctors.
The most common payment nature for GLYDERM is "Unspecified" ($58,350, 100.0% of total).
GLYDERM is associated with 2 research studies, including "The Effect of Cosmetic Face Peel Regimens on Skin Appearance" ($40,850).